Loading...
LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1.
Rastelli, Julia Hömig-Hölzel, Cornelia Seagal, Jane Müller, Werner Hermann, Andrea C Rajewsky, Klaus Zimber-Strobl, Ursula
Rastelli, Julia
Hömig-Hölzel, Cornelia
Seagal, Jane
Müller, Werner
Hermann, Andrea C
Rajewsky, Klaus
Zimber-Strobl, Ursula
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2008-02-01
Submitted date
Files
Loading...
original manuscript
Adobe PDF, 1.35 MB
Other Titles
Abstract
The Epstein-Barr virus (EBV) protein LMP1 is considered to be a functional homologue of the CD40 receptor. However, in contrast to the latter, LMP1 is a constitutively active signaling molecule. To compare B cell-specific LMP1 and CD40 signaling in an unambiguous manner, we generated transgenic mice conditionally expressing a CD40/LMP1 fusion protein, which retained the LMP1 cytoplasmic tail but has lost the constitutive activity of LMP1 and needs to be activated by the CD40 ligand. We show that LMP1 signaling can completely substitute CD40 signaling in B cells, leading to normal B-cell development, activation, and immune responses including class-switch recombination, germinal center formation, and somatic hypermutation. In addition, the LMP1-signaling domain has a unique property in that it can induce class-switch recombination to IgG1 independent of cytokines. Thus, our data indicate that LMP1 has evolved to imitate T-helper cell function allowing activation, proliferation, and differentiation of EBV-infected B cells independent of T cells.
Citation
LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. 2008, 111 (3):1448-55 Blood
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
0006-4971